This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies | MicrobiomeTrials
← Back to trials NCT07897669
A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10-21Est. Completion: 2027-04-01
Enrollment target: 5,122 participantsOther microbiome trials you might be interested in Malignant Germ Cell Tumor Lung Adenocarcinoma Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma Urothelial Carcinoma Endometrial Adenocarcinoma Ovarian Adenocarcinoma
DBC-664-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, …
Denver, United States Est. completion Apr 1, 2030
Advanced Urothelial Carcinoma Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Recurrent Urothelial Carcinoma
Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
Stage IV Bladder Urothelial Carcinoma AJCC v7
Unresectable Urothelial Carcinoma
This phase I/II trial studies the effect of eribulin mesylate and to see how well it works in treating patients with can…
Beverly Hills, United States Est. completion Jul 9, 2025
Muscle Invasive Bladder Urothelial Carcinoma Muscle Invasive Renal Pelvis Urothelial Carcinoma Muscle Invasive Ureter Urothelial Carcinoma Muscle Invasive Urethral Urothelial Carcinoma Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage IV Bladder Urothelial Carcinoma AJCC v7
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or uret…
Phoenix, United States Est. completion Sep 2, 2030